Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
Browse the full article libraryBoth from Eli Lilly and weekly, but Mounjaro is tirzepatide (dual action) and Trulicity is dulaglutide (GLP-1 only). Mounjaro is markedly stronger for weight.
Both from Eli Lilly and weekly, but Mounjaro is tirzepatide (dual action) and Trulicity is dulaglutide (GLP-1 only). Mounjaro is markedly stronger for weight.
Both from Eli Lilly and weekly, but Mounjaro is tirzepatide (dual action) and Trulicity is dulaglutide (GLP-1 only). Mounjaro is markedly stronger for weight.
Both from Eli Lilly and weekly, but Mounjaro is tirzepatide (dual action) and Trulicity is dulaglutide (GLP-1 only). Mounjaro is markedly stronger for weight.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Same molecule (semaglutide), different route. Ozempic is a weekly injection; Rybelsus is a daily tablet that must be taken fasted.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
Both target weight loss. Wegovy is semaglutide up to 2.4 mg; Mounjaro is tirzepatide up to 15 mg with dual hormone action and higher average loss in trials.
